{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01730",
      "entity_text" : "CD4",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06512",
      "entity_text" : "MHC class II alloantigen",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Whether the parenchymal expression of MHC class II alloantigen on human allografts can drive direct-pathway CD4 T cell activation has not been tested and seems unlikely, because clinical studies report this response to be short lived.",
  "reading_complete" : "2020-08-08T14:17:53Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:15:31Z",
  "trigger" : "drive",
  "evidence" : [ "MHC class II alloantigen on human allografts can drive direct-pathway CD4" ],
  "pmc_id" : "5405053",
  "score" : 0
}